Han Zhong Li
Director/Board Member at AIMFINITY INVESTMENT CORP. I
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Teng Wei Chen | M | 55 |
Inkstone Feibo Acquisition Corp.
 Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE. | 1 years |
| Hui Shao | M | 55 |
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 14 years |
| I Fa Chang | M | 43 |
Inkstone Feibo Acquisition Corp.
Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE. | 2 years |
| Cheng Liu | M | 57 |
Eureka Therapeutics, Inc.
 Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 18 years |
| Kevin Vassily | M | 56 |
Inkstone Feibo Acquisition Corp.
Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE. | 1 years |
| Shao Jing Tong | M | 53 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | - |
| Viren Mehta | M | 74 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 3 years |
| Chau Wai-Yan | M | - |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Yi Chang | M | 66 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 3 years |
| Xue Dong Tian | M | 52 | 1 years | |
| Ajit Shetty | M | 77 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 3 years |
| Gang Li | M | 42 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 5 years |
| Yuan Liu | M | 37 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 5 years |
| Hong Gang Teng | M | 51 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 7 years |
| Chun Yuan Wu | F | 46 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 11 years |
| Zhong Kai Shi | M | 59 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 4 years |
| Vivien Chan | M | - |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 10 years |
| William S. Solari | M | - |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Thomas Knapp | M | 71 | 6 years | |
| Simon Dazhong Lu | M | 55 | 6 years | |
| Wing Yat Lui | M | 35 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | - |
| Cheung Ki Wong | M | 41 | 6 years | |
| Jacqueline Northcut | F | 62 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Michael Cannon | M | 78 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Marvin Samson | M | 82 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Bo Feng | M | 53 |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Shao Meng Wang | M | 60 | 7 years | |
| Chih Kai Cheng | M | - |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
| Andrew W. Jeffrey | M | - |
Truist Securities, Inc.
 Truist Securities, Inc. Investment Banks/BrokersFinance Truist Securities, Inc. is a registered broker-dealer headquartered in Atlanta, Georgia. The firm was founded in 1894 as SunTrust Robinson Humphrey, Inc. In 2020, the firm was renamed following the integration of SunTrust Robinson Humphrey and BB&T Capital Markets. The firm is a subsidiary of Truist Financial Corp. (NYSE: TFC) and is an active market maker in equity and fixed-income products. Truist Securities delivers a comprehensive range of strategic advisory, capital raising, risk management, and financing solutions, as well as a dynamic suite of sales, trading, and research services in both fixed-income and equity. Their strategies are carefully tailored to meet the needs and vision of their clients. | 19 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Nathan Gregg | M | - |
Truist Securities, Inc.
Truist Securities, Inc. Investment Banks/BrokersFinance Truist Securities, Inc. is a registered broker-dealer headquartered in Atlanta, Georgia. The firm was founded in 1894 as SunTrust Robinson Humphrey, Inc. In 2020, the firm was renamed following the integration of SunTrust Robinson Humphrey and BB&T Capital Markets. The firm is a subsidiary of Truist Financial Corp. (NYSE: TFC) and is an active market maker in equity and fixed-income products. Truist Securities delivers a comprehensive range of strategic advisory, capital raising, risk management, and financing solutions, as well as a dynamic suite of sales, trading, and research services in both fixed-income and equity. Their strategies are carefully tailored to meet the needs and vision of their clients. | 17 years |
| Joshua Gordon | M | 52 | - | |
| James Long | M | 52 | 1 years | |
| Xin Wang | M | 51 | 1 years | |
| Sommer Kleweno Walley | F | - |
Washington State University
| 6 years |
| Jing Cao | M | 47 | - | |
| Bryan McDonald | M | 53 |
Washington State University
| 6 years |
| Adam Nichols | M | - |
Truist Securities, Inc.
Truist Securities, Inc. Investment Banks/BrokersFinance Truist Securities, Inc. is a registered broker-dealer headquartered in Atlanta, Georgia. The firm was founded in 1894 as SunTrust Robinson Humphrey, Inc. In 2020, the firm was renamed following the integration of SunTrust Robinson Humphrey and BB&T Capital Markets. The firm is a subsidiary of Truist Financial Corp. (NYSE: TFC) and is an active market maker in equity and fixed-income products. Truist Securities delivers a comprehensive range of strategic advisory, capital raising, risk management, and financing solutions, as well as a dynamic suite of sales, trading, and research services in both fixed-income and equity. Their strategies are carefully tailored to meet the needs and vision of their clients. | 15 years |
| Paul Tsutomu Carr | M | - |
Washington State University
| 5 years |
| Greg Zanghi | M | - |
Washington State University
| 3 years |
| Dal-Yeon Hwang | M | 63 |
Washington State University
| 5 years |
| Jeff Brown | M | - |
Washington State University
| 4 years |
| Al-Kackman | M | - |
Washington State University
| 4 years |
| Darlene Sammon | F | - |
UCLA Anderson School of Management
| 3 years |
| John Dubay | M | - |
Washington State University
| 5 years |
| Greg Headrick | M | - |
Washington State University
| 4 years |
| Claudina Elizabeth Campbell | F | 51 |
Washington State University
| 4 years |
| James Hagan | M | 51 |
UCLA Anderson School of Management
| 2 years |
| Lawrence M. Kahn | M | - |
UCLA Anderson School of Management
| 2 years |
| Ben Allen | M | 59 |
Washington State University
| 4 years |
| Linda Underwood | F | - |
Washington State University
| 2 years |
| Narinder Singh | M | 51 |
UCLA Anderson School of Management
| 2 years |
| Uday Babubhai Desai | M | 73 |
Washington State University
| 8 years |
| Taras Wibawa Siregar | M | 55 |
Washington State University
| 4 years |
| David Croom | M | 56 |
Washington State University
| 4 years |
| Susan Goodell Goldman | F | - |
UCLA Anderson School of Management
| 2 years |
| Katy Terrell | F | - |
UCLA Anderson School of Management
| 2 years |
| Marlo Oaks | M | - |
UCLA Anderson School of Management
| 3 years |
| John Heartwood Newman | M | - |
UCLA Anderson School of Management
| 2 years |
| Zhao Tong Xu | M | 63 |
Washington State University
| 2 years |
| Stephen Smith | M | - |
UCLA Anderson School of Management
| - |
| adam schlifke | M | - |
UCLA Anderson School of Management
| 2 years |
| John Ho | M | - |
UCLA Anderson School of Management
| 2 years |
| Peter Arnold | M | - |
UCLA Anderson School of Management
| 3 years |
| Nicole A. Fortener | F | - |
Washington State University
| 4 years |
| Ashley Lundblad | F | - |
Stanford Financial Group Ltd. (Texas)
 Stanford Financial Group Ltd. (Texas) Investment Banks/BrokersFinance Stanford Financial Group Ltd provides financial advisory services. The company is based in Houston, Texas. | 2 years |
| Jeffrey Brooks | M | - |
Washington State University
| 3 years |
| Phing Cern Yap | M | 61 |
Washington State University
| 4 years |
| James Bell | M | 59 |
Washington State University
| 4 years |
| Bruce Eaton | M | 70 |
Washington State University
| 11 years |
| Joe Gubler | M | - |
UCLA Anderson School of Management
| 3 years |
| Gregory Haendel | M | - |
UCLA Anderson School of Management
| 2 years |
| Mike Schimmel | M | - |
UCLA Anderson School of Management
| 2 years |
| Patrick Wasser | M | - |
UCLA Anderson School of Management
| 2 years |
| Grady Smith | M | - |
UCLA Anderson School of Management
| 3 years |
| Mike A. LaSalle | M | 51 |
UCLA Anderson School of Management
| 2 years |
| Michael Jamil Taila | M | - |
UCLA Anderson School of Management
| 2 years |
| Geoffrey Kelley | M | - |
Washington State University
| 4 years |
| Martin Ji | M | - |
UCLA Anderson School of Management
| 2 years |
| Phupinder Gill | M | 63 |
Washington State University
| 2 years |
| David Wang | M | 61 |
UCLA Anderson School of Management
| 2 years |
| Eric Chadwick | M | 48 |
UCLA Anderson School of Management
| 2 years |
| Karin Jo Lagerlund | F | - |
Washington State University
| 4 years |
| Christie L. Haas | F | - |
Washington State University
| 4 years |
| Peter Joseph Ungaro | M | 55 |
Washington State University
| 4 years |
| Gregory L. Myers | M | 68 |
Washington State University
| 3 years |
| Ken Lisaius | M | - |
Washington State University
| 4 years |
| Jody Underwood | F | - |
Washington State University
| 4 years |
| Bob Perrin | M | - |
Washington State University
| 4 years |
| Maura Robbins | F | - |
Washington State University
| 4 years |
| Philip M. Schwab | M | - |
Washington State University
| 4 years |
| Jay Cho | M | 59 |
Washington State University
| 3 years |
| Sai Keung Liu | M | 51 |
UCLA Anderson School of Management
| 2 years |
| Tran Nguyen | M | 50 |
UCLA Anderson School of Management
| 2 years |
| Phillip C. Ohl | M | - |
Washington State University
| 4 years |
| David Whitehead | M | - |
Washington State University
| 4 years |
| Jeff Parker | M | - |
Washington State University
| 4 years |
| Vic Leverett | M | 59 |
Washington State University
| 4 years |
| Edward Charles Reinhart | M | 52 |
Washington State University
| 4 years |
| Marc Stolzman | M | 57 |
Washington State University
| 4 years |
| Christopher Jenkins | M | - |
UCLA Anderson School of Management
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 85 | 85.00% |
| Cayman Islands | 11 | 11.00% |
| China | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Han Zhong Li
- Personal Network
